The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->
A new Lancet study of elite Swedish football players is the latest addition to a mounting pile of science linking high-level sports to the development of neurodegenerative conditions. The observational study tracked over 6,000 male footballers in Sweden’s top professional league between 1924 and 2019. It found they were 1.5 times more likely to develop […] Continue reading ->
Infant formula companies have “pathologised” normal baby behaviour to promote their products, and there should be “an international, legal treaty” to prevent their marketing,  according to health experts. In addition, political lobbying by milk formula companies to influence public policy should be sharply curtailed.  These are some of the suggestions contained in a three-part series […] Continue reading ->
When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading ->
Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading ->